Title of the centre:
WHO Collaborating Centre for Diagnostics and Laboratory Support for HIV/AIDS and Other Blood-borne Infections
Director / Head:
Ms Susan Best
National Serology Reference Laboratory (NRL)
St Vincent's Institute of Medical Research
4th Floor, Healy Building 41 Victoria Parade - 3065 Vic.
+61 3 9418 1123
(61-3) 9418 1155
Date of Designation:
Terms of Reference:
- To advise and provide quality assurance programmes for serological and virological diagnostic technologies for HIV and other blood borne infectious diseases, such as hepatitis B and hepatitis C in particular for the South East Asia and Western Pacific regions.
- To participate in the design and conduct WHO laboratory evalurations for prequalification of diagnostic technologies for HIV/AIDS and other blood borne infectious diseases, e.g. hepatitis B and hepatitis C.
- To collect and hold WHO repositories of relevant specimens for the assessment of diagnostic technologies for HIV/AIDS and other blood borne infectious diseases, e.g. hepatitis B and hepatitis C.
- To act as a reference laboratory on HIV/AIDS and other blood borne infectious diseases.
- To act as a source of technical information and continuing education for laboratory personnel. In addition provide advice, technical support and training as requested by WHO in the area of quality management systems to support national laboratory programmes providing diagnostic services.
- To act as a technical source for dossier assessments of HIV/AIDS and hepatitis B and hepatitis C diagnostics products for the purpose of prequalification
Types of activity:
- Information dissemination
- Provision of reference substances and other services
- Product development (guidelines; manual; methodologies; etc.)
WHO organization wide expected result:
2.3 - Global guidance and technical support provided on policies and programmes in order to promote equitable access to essential medicines, diagnostic tools and health technologies of assured quality for the prevention and treatment of HIV/AIDS, tuberculosis and malaria, and their rational use by prescribers and consumers, and, in order to ensure uninterrupted supplies of diagnostics, safe blood and blood products, injections and other essential health technologies and commodities.
VERCAUTEREN Gaby Henriette
+41 22 79 14728
WI Teodora Elvira
+41 22 79 14575
Access to annual progress reports and the current workplan (this is accessible to WHO Staff Members only):
Link to eWork